» Articles » PMID: 24365974

Snail-induced Epithelial-mesenchymal Transition Promotes Cancer Stem Cell-like Phenotype in Head and Neck Cancer Cells

Overview
Journal Int J Oncol
Specialty Oncology
Date 2013 Dec 25
PMID 24365974
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Head and neck squamous cell carcinoma (HNSCC) is known to have a poor prognosis. The resistance to treatment and distant metastasis are important clinical problems in HNSCC. The epithelial-mesenchymal transition (EMT) is a key process in successful execution of many steps such as the invasion and metastasis for cancer cells. Snail is one of the master regulators that promote EMT in many types of malignancies including HNSCC. Recently, it has been shown that Snail-induced EMT could induce a cancer stem cell (CSC)‑like phenotype in a number of tumor types. In this study, we investigated the role of Snail in inducing EMT properties and CSC-like phenotype in HNSCC. We established HNSCC cell lines transfected with Snail. E-cadherin was analyzed using western blot analysis and immunofluorescence staining. Cell migration and invasion were assessed using wound-healing assay and modified Boyden chamber assay, respectively. CSC markers of HNSCC, CD44 and aldehyde dehydrogenase 1 (ALDH1), were also evaluated with western blot analysis, and chemosensitivity was assessed with WST-8 assay. Introduction of Snail induced EMT properties in HNSCC cells and enhanced cell migration and invasion. Moreover, Snail-induced EMT gained CSC-like phenotype and was associated with increased chemoresistance. These results suggest that Snail could be one of the attractive targets for the development of therapeutic strategies in HNSCC.

Citing Articles

Cancer Stem Cells in Oral Squamous Cell Carcinoma: A Narrative Review on Experimental Characteristics and Methodological Challenges.

Acharya S, Shai S, Choon Y, Gunardi I, Hartanto F, Kadir K Biomedicines. 2024; 12(9).

PMID: 39335624 PMC: 11429394. DOI: 10.3390/biomedicines12092111.


Transcription Factors and Markers Related to Epithelial-Mesenchymal Transition and Their Role in Resistance to Therapies in Head and Neck Cancers.

Pawlicka M, Gumbarewicz E, Blaszczak E, Stepulak A Cancers (Basel). 2024; 16(7).

PMID: 38611032 PMC: 11010970. DOI: 10.3390/cancers16071354.


A Narrative Review on CD44's Role in Glioblastoma Invasion, Proliferation, and Tumor Recurrence.

Inoue A, Ohnishi T, Nishikawa M, Ohtsuka Y, Kusakabe K, Yano H Cancers (Basel). 2023; 15(19).

PMID: 37835592 PMC: 10572085. DOI: 10.3390/cancers15194898.


Cancer stem cells: an insight into the development of metastatic tumors and therapy resistance.

Nairuz T, Mahmud Z, Manik R, Kabir Y Stem Cell Rev Rep. 2023; 19(6):1577-1595.

PMID: 37129728 DOI: 10.1007/s12015-023-10529-x.


Therapeutic vulnerabilities of cancer stem cells and effects of natural products.

Reisenauer K, Aroujo J, Tao Y, Ranganathan S, Romo D, Taube J Nat Prod Rep. 2023; 40(8):1432-1456.

PMID: 37103550 PMC: 10524555. DOI: 10.1039/d3np00002h.